Skip to main content
Advanced Enzyme Technologies Limited logo

Advanced Enzyme Technologies Limited — Investor Relations & Filings

Ticker · ADVENZYMES ISIN · INE837H01020 LEI · 335800PWJRERMBTUUV90 BSE.NS Manufacturing
Open in API
Filings indexed 938 across all filing types
Latest filing 2024-05-17 Regulatory Filings
Country IN India
Listing BSE.NS ADVENZYMES

About Advanced Enzyme Technologies Limited

https://www.advancedenzymes.com/

Advanced Enzyme Technologies Limited is a research-driven company specializing in the development, manufacturing, and marketing of proprietary enzyme products and probiotics. The company operates across the entire enzyme value chain, from research and development to commercial-scale production. Its diverse portfolio serves multiple sectors, including human nutrition, animal nutrition, and industrial processing. Key applications encompass food and beverage production, dietary supplements, animal feed additives, and various industrial processes such as textiles, detergents, and pulp and paper manufacturing. With a focus on biotechnology and sustainable solutions, the firm leverages its extensive R&D capabilities to provide customized enzyme formulations. The company maintains a global footprint, supplying specialized biological solutions to a broad international client base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about a scheduled analyst/institutional investor meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details of the meeting date and participants. There is no financial data, no detailed presentation, no report attached or referenced, and no voting or management changes. The document is essentially an announcement of an upcoming investor meeting, not the meeting materials or transcript itself. Given the short length (1290 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for miscellaneous filings that do not fit other specific categories.
2024-05-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the availability of an audio recording of a conference call discussing the audited financial results for the quarter and year ended March 31, 2024. It mentions that the transcript will be provided later. The document itself does not contain the transcript or detailed financial data but is an announcement about the conference call recording and future transcript availability. The document length is short (1715 characters), and it serves as an intimation under regulatory requirements. Therefore, it is not the actual call transcript but an announcement related to it. According to the classification rules, such announcements about conference calls fall under Regulatory Filings (RNS) as a fallback category since it does not fit other specific categories and is not the full transcript.
2024-05-15 English
Updates
Notice of Dividend Amount Classification · 95% confidence The document is a communication from Advanced Enzyme Technologies Limited to shareholders regarding the declaration of an interim dividend for the financial year 2024-25. It details the tax deduction at source (TDS) provisions applicable to the dividend payment, including instructions for shareholders on submitting necessary documents for tax purposes. The document includes the dividend amount, record date, and extensive tax-related instructions but does not contain any financial statements, earnings data, or management analysis. It is an announcement related to dividend payment and tax withholding rather than a financial report or earnings release. Therefore, it fits the category of Notice of Dividend Amount (DIV). The document length is substantial and contains detailed information, confirming it is not a brief announcement or a report publication notice.
2024-05-13 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the newspaper publication of an extract of audited consolidated financial results for the quarter and year ended March 31, 2024. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions the extract was published in newspapers. The document itself does not contain the full financial statements or detailed financial analysis but is an announcement about the publication of the financial results extract. The length is about 15,000 characters, but the content is primarily an announcement of the publication of financial results, not the full report. Therefore, according to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the full Annual or Quarterly Report.
2024-05-13 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated May 11, 2024, announcing the audited financial results for the fourth quarter and full year ended March 2024 for Advanced Enzyme Technologies Limited. It contains detailed consolidated financial highlights, segmental revenue, geographical revenue, operational performance, and outlook for the company. The content includes actual financial data such as revenue, EBITDA, PAT, EPS, and segmental breakdowns for both quarterly and annual periods. The document is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, it fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights. The document is about 15,000 characters long, which supports it being a full earnings release rather than a brief announcement or regulatory filing. Hence, the appropriate classification is ER with high confidence.
2024-05-11 English
Investor Presentation
Earnings Release Classification · 95% confidence The document is titled 'Earnings Presentation May 2024' and is addressed pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed financial performance data for the quarter and year ended March 31, 2024, including revenue, EBITDA, PAT figures, segmental performance, and commentary on business segments. The document is a presentation format with forward-looking statements and detailed financial highlights, typical of an earnings presentation. It is not a full annual report or quarterly report with full financial statements, nor is it a brief earnings release. The document is not an announcement of a report but the report itself in presentation form. Therefore, the appropriate classification is 'Earnings Release' (ER) as it is the initial announcement of quarterly/yearly financial results with key highlights in presentation format.
2024-05-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.